Evidence map›Paper›PMID 33191671›Full record

ArticleMacromolecular bioscience2021

Anti-VEGF-R2 Aptamer and RGD Peptide Synergize in a Bifunctional Hydrogel for Enhanced Angiogenic Potential.

Tanaya Roy, Bryan D James, Josephine B Allen

Open access · greenAbstract read
In one paragraph

Article in Macromolecular bioscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Application of aptamers in regenerative medicine.Frontiers in bioengineering and biotechnology · 2022
    Pooled it
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Targeting Agents in Biomaterial-Mediated Bone Regeneration.International journal of molecular sciences · 2023
    Review
  18. Bioprinting Technologies and Bioinks for Vascular Model Establishment.International journal of molecular sciences · 2023
    Review
  19. Gene therapy to enhance angiogenesis in chronic wounds.Molecular therapy. Nucleic acids · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tanaya RoyDepartment of Materials Science and Engineering, University of Florida, Gainesville, FL, 32611, USA.ORCID 0000-0003-0939-7158
Bryan D JamesDepartment of Materials Science and Engineering, University of Florida, Gainesville, FL, 32611, USA.ORCID 0000-0002-6104-8310
Josephine B AllenDepartment of Materials Science and Engineering, University of Florida, Gainesville, FL, 32611, USA.ORCID 0000-0002-5676-0020
University of Florida · US

Funding

Vascular cell sexual dimorphism in complex mechanical microenvironmentsF31HL147445 · NHLBI · UNIVERSITY OF FLORIDA · PI JAMES, BRYAN DANIEL · 2019 to 2020
$69k
NHLBI NIH HHS F31 HL147445
6 · The paper itself

Abstract

Hydrogels have gained interest for use in tissue regeneration and wound healing because of their absorbing and swelling properties as well as their ability to mimic the natural extracellular matrix. Their use in wound healing specifically may be in the form of a patch or wound dressing or they may be administered within the wound bed as a filler, gel in situ, to promote healing. Thiolated hyaluronic acid-polyethylene diacrylate (tHA-PEGDA) hydrogels are ideal for this purpose due to their short gelation times at physiological temperature and pH. But these hydrogels alone are not enough and require added components to gain bioactivity. In this work, RGD adhesion peptides and an antivascular endothelial growth factor receptor-2 (VEGF-R2) DNA aptamer are incorporated into a tHA-PEGDA hydrogel to make a bifunctional hyaluronic acid hydrogel. RGD peptides promote attachment and growth of cells while the anti-VEGF-R2 DNA aptamer seems to improve cell viability, induce cell migration, and spur the onset of angiogenesis by tube formation by endothelial cells. This bifunctional hydrogel supports cell culture and has improved biological properties. The data suggest that these hydrogels can be used for advanced tissue regeneration applications such as in wound healing.

Indexed as

Neovascularization, PhysiologicAptamers, PeptideCell DeathCell MovementCell SurvivalHumansHuman Umbilical Vein Endothelial CellsHydrogelsOligopeptidesVascular Endothelial Growth Factor Receptor-2Aptamers, Peptidearginyl-glycyl-aspartic acidHydrogelsOligopeptidesVascular Endothelial Growth Factor Receptor-2DNA aptamershydrogelstissue engineeringVEGF-R2

Identifiers

PMID33191671
PMCPMC7880904
OpenAlexW3098669099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.